Momordica charantia fruit

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Momordica charantia fruit
DrugBank Accession Number
DB14265
Background

Momordica charantia fruit is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Type
Biotech
Groups
Experimental
Synonyms
  • African Cucumber
  • African Cucumber Fruit
  • Balsam Pear
  • Balsam Pear Fruit
  • Balsam-pear (Bitter Gourd), Pods, Raw
  • Balsam-pear (Bitter Gourd),pods,raw
  • Balsampear Fruit
  • Bitter Gourd
  • Bitter Gourd Fruit
  • Bitter Melon
  • Bitter Melon Fruit
  • Cucumis Argyi Fruit
  • Karavellaka Fruit
  • Ku Gua
  • Momordica Charantia Fruit Extract
  • Momordica Charantia Fruit Powder
  • Momordica Chinensis Fruit
  • Momordica Elegans Fruit
  • Momordica Fruit (Momordica Charantia)
  • Momordica Indica Fruit
  • Momordica Operculata Fruit
  • Momordica Sinensis Fruit
  • Sicyos Fauriei Fruit

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Dangsim K-7Granule13 g/100gOralKorea Genetic Pharm Co., Ltd2012-02-07Not applicableUS flag
Diabetes OutLiquid0.5 g/1mLOralCHANGJAE BENKO BIO Co., Ltd.2022-03-14Not applicableUS flag
Victory 19 Virus OutLiquid0.5 g/1mLOralCHANGJAE BENKO BIO Co., Ltd.2021-09-212022-03-14US flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Dangsim K-7Momordica charantia fruit (13 g/100g)GranuleOralKorea Genetic Pharm Co., Ltd2012-02-07Not applicableUS flag
Diabetes OutMomordica charantia fruit (0.5 g/1mL)LiquidOralCHANGJAE BENKO BIO Co., Ltd.2022-03-14Not applicableUS flag
Victory 19 Virus OutMomordica charantia fruit (0.5 g/1mL)LiquidOralCHANGJAE BENKO BIO Co., Ltd.2021-09-212022-03-14US flag

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
UA63Y8U89U
CAS number
Not Available

References

General References
Not Available
RxNav
1306885

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2CompletedTreatmentType 2 Diabetes Mellitus1
2WithdrawnTreatmentType 2 Diabetes Mellitus1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
GranuleOral13 g/100g
LiquidOral0.5 g/1mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at July 05, 2018 17:13 / Updated at June 12, 2020 16:53